PAUL KLOTMAN to Drug Therapy, Combination
This is a "connection" page, showing publications PAUL KLOTMAN has written about Drug Therapy, Combination.
Connection Strength
0.049
-
Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase. J Am Soc Nephrol. 2013 Apr; 24(5):801-11.
Score: 0.019
-
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney Int. 2012 May; 81(9):856-64.
Score: 0.017
-
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. J Clin Hypertens. 1987 Dec; 3(4):579-88.
Score: 0.013